CELLDEX THERAPEUTICS INC (CLDX)       27.81  +0.14 (+0.51%)

27.81  +0.14 (+0.51%)

US15117B2025 - Common Stock - After market: 27.81 0 (0%)

MRQ
(2022-6-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
ASSETS
Current Assets
Cash Equivalents
28.40M39.14M43.80M11.20M24.30M
Marketable Securities
328.42M369.11M150.60M53.20M69.70M
Receivables
97.00K172.00K1.80M1.00M3.20M
Other Current Assets
11.06M2.42M1.60M1.30M1.90M
Total Current Assets
367.98M410.84M197.80M66.70M99.10M
 
Non-Current Assets
PPE Net
7.69M6.52M7.30M7.50M6.10M
Intangibles
27.19M27.19M30.70M48.70M48.70M
Other Non-Current Assets
104.00K104.00K0.000.001.90M
Other Assets
N/AN/AN/AN/AN/A
Total Non-Current Assets
34.98M33.81M38.00M56.20M56.70M
 
TOTAL ASSETS
402.96M444.65M235.80M122.90M155.80M
 
LIABILITIES
Current Liabilities
Short Term Debt
0.000.000.000.000.00
Accounts Payable And Accrued Liabilities
902.00K1.23M1.00M1.20M1.10M
Accrued Expenses
12.65M13.75M9.80M8.40M7.00M
Other Current Liabilities
16.39M1.55M3.40M2.00M4.50M
Total Current Liabilities
29.95M16.53M14.20M11.60M12.60M
 
Non-Current Liabilities
Long Term Debt
0.000.000.000.000.00
Deferred Taxes/Income
N/AN/A1.80M4.80M7.20M
Other Non-Current Liabilities
7.92M8.65M10.40M12.40M11.90M
Total Non-Current Liabilities
7.92M8.65M12.30M17.30M19.10M
 
TOTAL LIABILITIES
37.87M25.18M26.50M28.90M31.70M
 
SHAREHOLDERS' EQUITY
Additional Paid In Capital
1.57B1.56B1.28B1.10B1.08B
Shares Outstanding
46.76M46.73M39.60M17.00M12.00M
Common Shares
47.00K47.00K0.000.000.00
Retained Earnings
-1.20B-1.14B-1.07B-1.01B-962.40M
Other Shareholders' Equity
2.60M2.60M2.60M2.60M2.60M
Total Shareholders' Equity
365.09M419.48M209.40M94.00M124.10M
 
TOTAL LIABILITIES AND EQUITY
402.96M444.65M235.80M122.90M155.80M
 
Statistics
Debt/Equity
N/AN/AN/AN/AN/A
Current Ratio
12.2924.8613.935.757.87
Return On Assets (ROA)
-24.73%-15.86%-25.35%-41.40%-97.03%
Return On Equity (ROE)
-27.30%-16.81%-28.55%-54.13%-121.82%

All data in USD

Charts